{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:12:03Z","timestamp":1790118723571,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ejpb.2020.05.029","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T19:41:02Z","timestamp":1590867662000},"page":"307-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Oral delivery and enhanced efficacy of antimonal drug through macrophage-guided multifunctional nanocargoes against visceral Leishmaniasis"],"prefix":"10.1016","volume":"152","author":[{"given":"Hafiz","family":"Shoaib Sarwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Varikuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Farhan Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay R.","family":"Satoskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul","family":"Shahnaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.05.029_b0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/cbdd.12831","article-title":"In-vitro antileishmanial potential of peptide drug hirudin","volume":"89","author":"Khan","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejpb.2020.05.029_b0010","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.2217\/nnm-2017-0233","article-title":"Biosynthesized colloidal silver and gold nanoparticles as emerging leishmanicidal agents: an insight","volume":"12","author":"Ovais","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2020.05.029_b0015","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2217\/nnm-2017-0049","article-title":"Redox biology of Leishmania and macrophage targeted nanoparticles for therapy","volume":"12","author":"Sarwar","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2020.05.029_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2217\/nnm-2017-0255","article-title":"Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis","volume":"13","author":"Sarwar","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2020.05.029_b0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jim.2015.04.022","article-title":"Uncovering Leishmania\u2013macrophage interplay using imaging flow cytometry","volume":"423","author":"Terrazas","year":"2015","journal-title":"J. Immunolog. Meth."},{"key":"10.1016\/j.ejpb.2020.05.029_b0030","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot5080","article-title":"Bone marrow-derived macrophages (BMM): isolation and applications","author":"Weischenfeldt","year":"2008","journal-title":"Cold Spring Harbor Protocols"},{"key":"10.1016\/j.ejpb.2020.05.029_b0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2003.10.005","article-title":"Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system","volume":"94","author":"Bernkop-Schn\u00fcrch","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.05.029_b0040","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1039\/C4NR03962A","article-title":"Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages","volume":"7","author":"Ortega","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2020.05.029_b0045","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/0885328214540349","article-title":"Fluorescent chitosan functionalized magnetic polymeric nanoparticles: Cytotoxicity and in vitro evaluation of cellular uptake","volume":"29","author":"Kaewsaneha","year":"2014","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.ejpb.2020.05.029_b0050","article-title":"Amphiphilic antimony (V) complexes for oral treatment of visceral leishmaniasis","volume":"AAC","author":"Fernandes","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2020.05.029_b0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1021\/acsinfecdis.5b00081","article-title":"A Novel Sterol Isolated from a Plant Used by Mayan Traditional Healers Is Effective in Treatment of Visceral Leishmaniasis Caused by Leishmania donovani","volume":"1","author":"Gupta","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejpb.2020.05.029_b0060","first-page":"21","article-title":"Recent advances in vaccines against Leishmania based on patent applications, Recent patents on","volume":"12","author":"Thomaz-Soccol","year":"2018","journal-title":"Biotechnology"},{"key":"10.1016\/j.ejpb.2020.05.029_b0065","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.05.029_b0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.05.029_b0075","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1039\/C6TB01348A","article-title":"Folate grafted thiolated chitosan enveloped nanoliposomes with enhanced oral bioavailability and anticancer activity of docetaxel","volume":"4","author":"Sohail","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejpb.2020.05.029_b0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejps.2016.09.031","article-title":"Enhancing the efficiency of thiomers: Utilizing a highly mucoadhesive polymer as backbone for thiolation and preactivation","volume":"96","author":"Pr\u00fcfert","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.05.029_b0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(99)00058-2","article-title":"Modeling of drug release from swellable polymers","volume":"49","author":"Brazel","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.05.029_b0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0939-6411(03)00157-7","article-title":"Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation","volume":"57","author":"Roldo","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.05.029_b0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2011.09.010","article-title":"Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide","volume":"80","author":"Iqbal","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.05.029_b0100","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1039\/C7TX00146K","article-title":"Cell to rodent: toxicological profiling of folate grafted thiomer enveloped nanoliposomes","volume":"6","author":"Sohail","year":"2017","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.ejpb.2020.05.029_b0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2217\/nnm-2016-0325","article-title":"Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis","volume":"12","author":"Shahnaz","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2020.05.029_b0110","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/mp500527x","article-title":"Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles","volume":"12","author":"Serrano","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.05.029_b0115","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1128\/AAC.00639-13","article-title":"Amphiphilic antimony (V) complexes for oral treatment of visceral leishmaniasis","volume":"57","author":"Fernandes","year":"2013","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120301569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120301569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:39:30Z","timestamp":1760546370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120301569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":23,"alternative-id":["S0939641120301569"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.05.029","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral delivery and enhanced efficacy of antimonal drug through macrophage-guided multifunctional nanocargoes against visceral Leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}